SCHEMBL3146944

SCHEMBL3146944

O=C(Nc1cccc(F)c1)OCCc1ccc2c(n1)N(C(=O)O)CCC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.41
RAB9A P51151 3/20 0.41
CASP3 P42574 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
ALDH1A1 P00352 3/20 0.39
ITGB3 P05106 1/20 0.39
ITGAV P06756 1/20 0.39
ITGB6 P18564 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
MGLL Q99685 1/20 0.39
CYP2D6 P10635 2/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
USP2 O75604 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3138440 0.79 ITGB3 (0.57) ITGB3ITGAVITGB6
SCHEMBL3140159 0.72 SMN1; SMN2 (0.38) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL5823603 0.71 FGFR4 (0.36) MEN1KMT2ASMN1; SMN2
SCHEMBL28311247 0.70 FGFR4 (0.35) ITGB3ITGAVMEN1KMT2ASMN1; SMN2
SCHEMBL20140313 0.69 NOTUM (0.40) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL20141262 0.69 FGFR4 (0.39) MEN1KMT2ASMN1; SMN2
SCHEMBL21328960 0.69 ITGAV (0.37) ITGB3ITGAVITGB6MEN1KMT2A
SCHEMBL28337910 0.68 ITGAV (0.40) ITGB3ITGAVITGB6CYP3A4
SCHEMBL3095932 0.68 FGFR4 (0.40) ALDH1A1MEN1KMT2AKDM4E
SCHEMBL28337154 0.68 ITGAV (0.36) ITGB3ITGAVITGB6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010057101-A2 COMPOUNDS USEFUL AS HIV BLOCKERS SCHERING CORPORATION (US) 2010-05-20 WO disclosed